Evidence map›Paper›PMID 31468296›Full record

ArticleAIDS and behavior2019

PrEP Implementation and Persistence in a County Health Department Setting in Atlanta, GA.

Charlotte-Paige Rolle, Udodirim Onwubiko, Jennifer Jo, Anandi N Sheth, Colleen F Kelley, David P Holland

Abstract read
In one paragraph

Article in AIDS and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. PrEP Persistence Support and Monitoring in Areas of High HIV Burden in the Midwestern United States.AIDS education and prevention : official publication of the International Society for AIDS Education · 2023
    Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charlotte-Paige RolleOrlando Immunology Center, 1707 North Mills Avenue, Orlando, 32803, FL, USA. crolle@emory.edu.ORCID http://orcid.org/0000-0002-6444-2225
Udodirim OnwubikoFulton County Board of Health, Atlanta, GA, USA.
Jennifer JoEmory University School of Medicine, Atlanta, GA, USA.
Anandi N ShethDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Colleen F KelleyDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
David P HollandFulton County Board of Health, Atlanta, GA, USA.

Funding

Characterization and modulation of mucosal immunity for HIV prevention in womenK23AI114407 · NIAID · EMORY UNIVERSITY · PI SHETH, ANANDI NAYAN · 2014 to 2018
$898k
Defining the rectal mucosa in MSM at risk of HIV infectionK23AI108335 · NIAID · EMORY UNIVERSITY · PI KELLEY, COLLEEN F · 2013 to 2017
$855k
NIAID NIH HHS K23 AI108335NIAID NIH HHS K23 AI114407NIH HHS K23AI108335NIH HHS K23AI114407
6 · The paper itself

Abstract

For marginalized populations, county health departments may be important PrEP access points; however, there are little data on successful PrEP programs at these venues outside of incentivized demonstration projects. Therefore, we implemented an open-access, free PrEP clinic at a county health department in Atlanta, GA to promote PrEP uptake among high-risk clients. The Fulton County Board of Health PrEP clinic launched in October 2015, and eligible clients who expressed interest initiated PrEP and attended follow-up visits per CDC guidelines. Clients engaged in quarterly follow-up and seen within the last 6 months were defined as "persistent", whereas clients with a lapse in follow-up of > 6 months were defined as "not persistent." Factors associated with PrEP persistence were assessed with unadjusted odds ratios. Between October 2015 and June 2017, 399 clients were screened for PrEP, almost all were eligible [392/399 (98%)]; however, 158/392 (40%) did not return to start PrEP after screening. Of 234 patients, 216 (92%) received a prescription for PrEP. As of June 2017, only 69/216 (32%) clients remained persistent in PrEP care, and the only evaluated factor significantly associated with PrEP persistence was age ≥ 30 years (OR 1.86, 95% CI 1.02, 3.42). Implementation of PrEP in the county health department setting is feasible; however, we have identified significant challenges with PrEP uptake and persistence in our setting. Further research is needed to fully understand mediators of PrEP persistence and inform interventions to optimize health department-based PrEP services.

Indexed as

AdultAnti-HIV AgentsFemaleGeorgiaHIV InfectionsHumansMaleMiddle AgedPatient Acceptance of Health CarePre-Exposure ProphylaxisPublic Health PracticeAnti-HIV AgentsAtlantaHealth departmentHIV preventionPrEP adherencePrEP implementationPrEP persistence

Identifiers

PMID31468296
PMCPMC6800647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.